Editorial
Copyright ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Mar 26, 2017; 9(3): 207-211
Published online Mar 26, 2017. doi: 10.4330/wjc.v9.i3.207
Coronary stenting: A matter of revascularization
Aldo Bonaventura, Fabrizio Montecucco, Luca Liberale
Aldo Bonaventura, Fabrizio Montecucco, Luca Liberale, First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa School of Medicine and IRCCS Azienda Ospedaliera Universitaria San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, 16132 Genoa, Italy
Author contributions: Bonaventura A, Montecucco F and Liberale L wrote the article; Bonaventura A and Liberale L designed the figure; Montecucco F supervised the drafting of the entire article.
Conflict-of-interest statement: Bonaventura A, Montecucco F and Liberale L declare no conflict of interest related to this publication.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Fabrizio Montecucco, MD, PhD, Associate Professor, First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa School of Medicine and IRCCS Azienda Ospedaliera Universitaria San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, 6 viale Benedetto XV, 16132 Genoa, Italy. fabrizio.montecucco@unige.it
Telephone: +39-010-3538694 Fax: +39-010-3538686
Received: October 12, 2016
Peer-review started: October 17, 2016
First decision: November 14, 2016
Revised: November 15, 2016
Accepted: December 7, 2016
Article in press: December 9, 2016
Published online: March 26, 2017
Processing time: 165 Days and 0.5 Hours
Core Tip

Core tip: Percutaneous coronary intervention (PCI) has made progress in leaps and bounds in the last 20 years. Complications occurring with catheter balloons and bare metal stents have been overwhelmed by drug-eluting stents (DESs), especially the new-generation ones. They are characterized by innovations in design, metal composition, surface polymers, and anti-proliferative drugs, thus reducing the risk for stent thrombosis and greatly improving revascularization outcomes. DESs also need dual antiplatelet therapy (DAPT), but the latter implies bleeding complications, too. Patients undergoing PCI should be implanted with DESs and DAPT should be tailored on each patient considering the bleeding risk.